According to the postoperative pathological results, there were no significant differences in age, maximum size of breast lesions, histological type, tumor grade, ER status, PR status, HER2 status, Ki-67 status and molecular subtype between low and high lymph node burden groups in training cohort. The gene discussed is ERBB2; the disease is medical procedure.